Core Viewpoint - Yunzhisheng has been officially included in the Hong Kong Stock Connect list, reflecting strong market recognition and opening new opportunities for liquidity and financing, following its successful listing as the "first AGI stock" in Hong Kong [1][12]. Financial Performance - In the first half of 2025, Yunzhisheng reported a revenue of 405 million RMB, achieving a year-on-year growth of 20.2%, demonstrating resilience amid increasing competition in the AI industry [3]. - The revenue from large model-related businesses surged by 457% year-on-year, nearing 100 million RMB, showcasing the company's ability to convert technology into commercial value [5]. - The AI chip sales reached 16.5 million units in the first half of the year, with cumulative shipments exceeding 100 million units, supporting daily life applications [5]. - The insurance business revenue skyrocketed by 1386.8% year-on-year, indicating a significant breakthrough and new growth trajectory [5]. - In the high-value "AI + healthcare" sector, the average revenue per customer increased by 116.2% year-on-year, highlighting market recognition of its healthcare AI solutions [5]. Technological Advancements - Yunzhisheng has intensified its investment in technology research and development, focusing on its self-developed Atlas intelligent computing platform to strengthen technological barriers [6]. - The company successfully compressed model parameters to below 0.5 billion through advanced model distillation technology, developing high-performance, low-latency edge models that have been successfully delivered in various vehicle models [6]. - The company has expanded its language model capabilities to cover multiple languages and dialects, enhancing speech recognition and semantic understanding in multilingual environments [8]. Market Expansion and Policy Support - Yunzhisheng has accelerated its domestic and international collaboration, signing memorandums with the government of Vanuatu and establishing a project in Southeast Asia [10]. - The company has formed strategic partnerships with health authorities and insurance companies in China, deepening its penetration in core sectors [10]. - Recent government policies promoting the integration of AI with various industries align with Yunzhisheng's strategic direction, providing a favorable environment for its growth [12].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 承董事會命 （股份代號：9678） 公 告 暫停辦理股份過戶登記手續 雲知聲智能科技股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司擬於2025 年10月17日（星期五）舉行2025年第二次臨時股東大會（「臨時股東大會」）。 為確定有權出席臨時股東大會並於會上投票的本公司H股股東名單，本公司將自2025年 9月27日（星期六）起至2025年10月17日（星期五）止期間（包括首尾兩日）暫停辦理H股股份 過戶登記，該期間不辦理H股股份過戶登記手續。於2025年10月17日（星期五）名列本公 司股東名冊的H股股東將有權出席臨時股東大會並可於會上投票。 載有於臨時股東大會上提呈的決議案詳情的通函連同臨時股東大會的通告將分別在香 港聯合交易所有限公司披露易網站( w ...

港股三大指数今日全线下跌，"AI解決方案提供商"云知声(9678.HK)逆势大涨26.55%至591港元。消息面上，云知声昨日晚间公告，公司已于本公告日期向中 国证监会提交申请，以将公司24,488,277股境内非上市股份及4,570,649股非上市外资股(统称"非上市股份")转为公司H股。 在取得所有相关监管机构(包括但不限于中国证监会及联交所)的备案及╱或批准及符合所有适用法律法规后，该等非上市股份将被转为H股及合资格在联交 所主板上市买卖。截至本公告日期，公司尚未就该申请完成中国证监会的备案。公司将于适当时候就申请的进展及详情作出进一步公告。(格隆汇) ...

Core Insights - Cloud Wisdom (09678.HK) has been officially included in the Hang Seng Composite Index and the Hong Kong Stock Connect, reflecting strong market recognition of its capabilities in medical AI applications [1][3] - The inclusion was anticipated by Huatai Securities, which highlighted that Cloud Wisdom met the criteria for inclusion based on market capitalization (over HKD 40 billion), liquidity, and listing duration [3] - The company has established a three-layer technological framework that supports its growth, consisting of a robust AI infrastructure, a large medical model, and application solutions focused on healthcare and daily life [3][4] Company Performance - The medical AI solution has demonstrated significant efficiency improvements, with an 80% increase in medical record entry efficiency and a 15% reduction in doctor consultation time [4] - The adoption rate of generated medical records is as high as 98%, indicating strong acceptance in clinical settings [4] - The average revenue per medical client surged by 116.2% year-on-year to CNY 1.013 million, while revenue from insurance technology services skyrocketed by 1386.8% to CNY 9.963 million [6] Market Position - Cloud Wisdom ranks fourth in the Chinese market for medical AI solutions, with revenue from its large medical model growing by 457.4% in the first half of the year [6] - The rapid inclusion in the Hang Seng Index not only reflects confidence in the AI healthcare sector but also highlights the rarity of its combination of advanced technology and deep market applications [6] - The influx of funds from the Hong Kong Stock Connect is expected to accelerate Cloud Wisdom's expansion in smart healthcare and insurance technology sectors [6]

Core Viewpoint - The company, Yunzhisheng (09678.HK), has submitted an application to the China Securities Regulatory Commission (CSRC) to convert a total of 24,488,277 domestic unlisted shares and 4,570,649 unlisted foreign shares into H-shares for listing on the Hong Kong Stock Exchange [1] Group 1 - The total number of shares to be converted includes 24,488,277 domestic unlisted shares and 4,570,649 unlisted foreign shares [1] - The conversion of these shares into H-shares is subject to approval from relevant regulatory bodies, including the CSRC and the Hong Kong Stock Exchange [1] - As of the date of the announcement, the company has not yet completed the filing with the CSRC regarding this application [1] Group 2 - The company will provide further announcements regarding the progress and details of the application at an appropriate time [1]

智通财经APP讯，云知声(09678)发布公告，公司已于本公告日期向中国证监会提交申请，以将公司 2448.83万股境内非上市股份及457.06万股非上市外资股(统称非上市股份)转为公司H股。在取得所有相 关监管机构(包括但不限于中国证监会及联交所)的备案及╱或批准及符合所有适用法律法规后，该等非 上市股份将被转为H股及合资格在联交所主板上市买卖。 ...

云知声(09678)发布公告，公司已于本公告日期向中国证监会提交申请，以将公司2448.83万股境内非上 市股份及457.06万股非上市外资股(统称非上市股份)转为公司H股。在取得所有相关监管机构(包括但不 限于中国证监会及联交所)的备案及╱或批准及符合所有适用法律法规后，该等非上市股份将被转为H 股及合资格在联交所主板上市买卖。 ...

本公告乃由雲知聲智能科技股份有限公司（「本公司」）根據香港聯合交易所有限公司證 券上市規則（「上市規則」）第13.09條及證券及期貨條例第XIVA部作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：9678） 內幕消息 本公司申請股份全流通 本次股份全流通以及轉換及上市尚須履行中國證監會、聯交所及其他境內外監管機構 所要求的其他相關程序。本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 雲知聲智能科技股份有限公司 茲提述中國證券監督管理委員會（「中國證監會」）於2019年11月14日發佈並於2023年8月 10日修訂的《H股公司境內未上市股份申請「全流通」業務指引》及於2023年2月17日發佈 的《境內企業境外發行證券和上市管理試行辦法》有關香港聯合交易所有限公司（「聯交 所」）上 ...

Core Viewpoint - Yunzhisheng (09678) has experienced a significant decline in stock price, dropping nearly 40% over three trading days after being included in the Hong Kong Stock Connect, despite previous highs in the month prior [1] Group 1: Stock Performance - The stock price of Yunzhisheng fell over 17% during intraday trading and opened high but closed down more than 18% on the day of inclusion in the Hong Kong Stock Connect [1] - The stock has seen a cumulative decline of nearly 40% over three consecutive trading days, returning to levels prior to August [1] - As of the latest report, the stock is down 11.49%, trading at 468.2 HKD with a transaction volume of 119 million HKD [1] Group 2: Company Financials - In the first half of the year, Yunzhisheng reported revenue of 405 million RMB, reflecting a year-on-year growth of 20.2% [1] - The company recorded a loss attributable to shareholders of 297 million RMB, which is an increase of 16.4% year-on-year [1] - Over the past three years, the company has consistently reported losses, with projected losses of 375 million RMB, 376 million RMB, and 454 million RMB for the years 2022 to 2024, totaling 1.205 billion RMB [1] Group 3: Debt Situation - As of the end of 2024, the company is expected to have redeemable liabilities amounting to 3.303 billion RMB [1]

近期，恒生指数公司公布截至2025年6月30日的恒生指数系列季度检讨结果，云知声(09678)成功获纳入恒生综合指数，该调整已于9月8日正式生效，沪深交 易所也同步调整港股通可投资标的范围。据华泰证券研报分析，云知声此次顺利调入港股通，核心在于满足了市值、流动性、上市时间等一系列核心筛选标 准，这一动作已率先凸显资本市场对其基本面与发展潜力的认可。 作为"港股AGI第一股"，云知声上市后发展有目共睹，其发布上市后首份中期业绩报告数据更凸显出资本市场对AGI赛道优质企业的认可，同时印证了公司 在技术转化与业务布局上的前瞻性。 更关键的营收质的突破，成为本次中报的核心亮点。云知声自主研发的"山海大模型"相关业务，上半年实现收入9876万元，较去年同期的1771.8万元大幅增 长457.4%，占上半年总收入近25%。这一数据标志着两大转变：一是公司新增核心增长引擎，二是商业模式从劳动密集型的项目制，向技术密集型的平台/ 模型服务转型。转型后，公司既能更高效满足客户多样化需求，又降低了对单一项目的依赖，为业务稳定性与可持续性奠定基础，同时也是前期巨额研发投 入转化为商业回报的直接体现。 业务的"量稳质升"，离不开持续 ...